Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis

NCT03231033 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Pulmonary Alveolar Proteinosis

Interventions

DRUG: Pioglitazone

Sponsor

Children's Hospital Medical Center, Cincinnati